Latest Regulatory Risk News

Page 14 of 25
Solvar Limited’s FY25 results highlight solid loan book growth in Australia, the strategic launch of Bennji commercial finance, and a significant 40% increase in dividends, underpinning confidence in future earnings.
Claire Turing
Claire Turing
28 Aug 2025
Clinuvel Pharmaceuticals has reported a robust financial year ending June 2025, marked by solid revenue growth and sustained profitability, while advancing its clinical pipeline and maintaining a strong balance sheet.
Ada Torres
Ada Torres
28 Aug 2025
Zoono Group Limited reported a 19.1% revenue increase to NZ$1.25 million for FY2025, alongside a significantly reduced net loss. The company is pivoting towards B2B markets, focusing on antimicrobial and shelf-life extension technologies, supported by a recent AUD 1.78 million capital raise.
Ada Torres
Ada Torres
28 Aug 2025
Perpetual Limited reported a steady FY25 with underlying profit after tax of $204.1 million, revenue growth across all segments, and a net loss narrowed to $58.2 million. The firm’s refreshed strategy focuses on simplification, operational excellence, and measured growth investments amid evolving regulatory landscapes.
Claire Turing
Claire Turing
28 Aug 2025
Micro-X Limited reported a $13.9 million loss for FY2025 as it pivots towards medical imaging, securing a landmark supply agreement with a major US healthcare provider for its Rover Plus mobile X-ray system.
Ada Torres
Ada Torres
28 Aug 2025
Qantas Airways posted a robust FY25 financial performance with a 28% rise in statutory profit after tax, supported by strong travel demand and strategic fleet investments. The Group also announced substantial dividends and completed a $431 million share buy-back, while closing Jetstar Asia to focus on core markets.
Victor Sage
Victor Sage
28 Aug 2025
Atlas Arteria reported an 11.4% rise in revenue for the half year ended June 2025, driven by toll growth across its global portfolio. However, net profit fell 32.9% due to a one-off French tax and ongoing challenges in the US.
Nora Hopper
Nora Hopper
28 Aug 2025
Medibank Private Limited reported steady revenue growth and stable profit for FY25, while navigating ongoing cybercrime-related expenses and regulatory scrutiny. The insurer also announced increased dividends and outlined strategic investments in health services and digital transformation.
Ada Torres
Ada Torres
28 Aug 2025
Mineral Resources Limited posted a $896 million statutory loss for FY25, driven by significant impairments, while Onslow Iron achieved commercial production and governance reforms reshape the board.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Kina Securities Limited reported a robust 37% jump in statutory net profit after tax for the half year ended June 2025, driven by solid revenue growth and expanding loan portfolios. The bank also declared a higher interim dividend, reflecting confidence in its financial strength.
Claire Turing
Claire Turing
27 Aug 2025
Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.
Victor Sage
Victor Sage
27 Aug 2025
MyEco Group reported a 9% increase in FY25 sales driven by an 82% jump in MyEco branded products, alongside a strategic operational restructure aimed at cutting costs and boosting supply chain flexibility.
Victor Sage
Victor Sage
27 Aug 2025